Oculis Holding AG (OCS) Net Cash Flow (QoQ) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.50% |
| Dec 31, 2025 | 546.62% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | -121.29% |
| Mar 31, 2025 | 1,140.28% |
| Dec 31, 2024 | 31.95% |
| Sep 30, 2024 | -159.33% |
| Jun 30, 2024 | 225.77% |
| Mar 31, 2024 | -273.18% |
| Dec 31, 2023 | 159.44% |
| Sep 30, 2023 | -177.09% |
| Jun 30, 2023 | -73.85% |
| Mar 31, 2023 | 1,096.41% |
| Dec 31, 2022 | -52.23% |